MARSH & MCLENNANS ($MMC) posted quarterly earnings results on Thursday, October 16th. The company reported earnings of $1.85 per share, beating estimates of $1.81 by $0.04. The company also reported revenue of $6,351,000,000, missing estimates of $6,386,230,151 by $-35,230,151.
You can see Quiver Quantitative's $MMC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
MARSH & MCLENNANS Insider Trading Activity
MARSH & MCLENNANS insiders have traded $MMC stock on the open market 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $MMC stock by insiders over the last 6 months:
- JOHN Q DOYLE (President and CEO) sold 21,080 shares for an estimated $4,891,614
- ANTHONY ANDERSON has made 2 purchases buying 1,000 shares for an estimated $201,612 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MARSH & MCLENNANS Hedge Fund Activity
We have seen 702 institutional investors add shares of MARSH & MCLENNANS stock to their portfolio, and 739 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS added 3,211,310 shares (+48.8%) to their portfolio in Q2 2025, for an estimated $702,120,818
- VALEO FINANCIAL ADVISORS, LLC added 2,623,745 shares (+48212.9%) to their portfolio in Q2 2025, for an estimated $573,655,606
- SOUNDWATCH CAPITAL LLC added 2,565,037 shares (+inf%) to their portfolio in Q2 2025, for an estimated $560,819,689
- FMR LLC removed 2,114,616 shares (-9.5%) from their portfolio in Q2 2025, for an estimated $462,339,642
- MACKENZIE FINANCIAL CORP added 1,554,114 shares (+212.6%) to their portfolio in Q2 2025, for an estimated $339,791,484
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,515,596 shares (+17.8%) to their portfolio in Q2 2025, for an estimated $331,369,909
- AMUNDI added 1,363,706 shares (+89.2%) to their portfolio in Q2 2025, for an estimated $298,160,679
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
MARSH & MCLENNANS Congressional Stock Trading
Members of Congress have traded $MMC stock 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $MMC stock by members of Congress over the last 6 months:
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 09/16.
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 05/15.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
MARSH & MCLENNANS Analyst Ratings
Wall Street analysts have issued reports on $MMC in the last several months. We have seen 2 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 10/09/2025
- UBS issued a "Buy" rating on 07/21/2025
- Keefe, Bruyette & Woods issued a "Underperform" rating on 07/09/2025
To track analyst ratings and price targets for MARSH & MCLENNANS, check out Quiver Quantitative's $MMC forecast page.
MARSH & MCLENNANS Price Targets
Multiple analysts have issued price targets for $MMC recently. We have seen 7 analysts offer price targets for $MMC in the last 6 months, with a median target of $222.0.
Here are some recent targets:
- Jimmy Bhullar from JP Morgan set a target price of $242.0 on 10/09/2025
- Elyse Greenspan from Wells Fargo set a target price of $222.0 on 10/08/2025
- Alex Scott from Barclays set a target price of $221.0 on 10/08/2025
- Brian Meredith from UBS set a target price of $257.0 on 10/08/2025
- Michael Phillips from Morgan Stanley set a target price of $215.0 on 10/07/2025
- Matthew Heimermann from Citigroup set a target price of $226.0 on 08/13/2025
- Meyer Shields from Keefe, Bruyette & Woods set a target price of $210.0 on 07/21/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
